ArticleCancer causes & control : CCC2025
Association between dietary intake and urinary concentrations of caffeine and caffeine metabolites and elevated serum prostate-specific antigen (PSA) among men at risk for prostate cancer.
Article in Cancer causes & control : CCC, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeProstatic chronic inflammation has been found to be associated with prostate cancer risk. Caffeine intake has shown to exhibit anti-inflammatory properties. The relationship between caffeine and prostatic inflammation remains not known. We examined whether dietary intake and urinary concentration of caffeine and its metabolites are associated with serum prostate-specific antigen (PSA) levels, a surrogate marker of prostatic inflammation, among prostate cancer-free men.
methodsCancer-free men, aged ≥ 40 years, with dietary caffeine intake and serum PSA results were identified from the 2001-2010 National Health and Nutrition Examination Survey. Elevated serum PSA was based on age- and race-specific definitions. Weighted logistic regression analysis with survey sample weights was used to examine the association between dietary intake and urinary concentration of caffeine and its metabolites and elevated serum PSA.
resultsThere were 5,456 men included. Approximately 6.4% of them had an elevated serum PSA. Men with an elevated serum PSA (geometric mean: 63.4 mg) had statistically significantly lower dietary caffeine intake compared to men with a normal serum PSA (geometric mean: 80.9 mg) (p value < 0.01). After adjusting for confounders, dietary caffeine intake and urinary caffeine and its metabolites concentrations were not statistically significantly associated with elevated serum PSA.
conclusionMen with elevated serum PSA had lower dietary caffeine intake compared to men with a normal serum PSA. However, dietary caffeine intake and urinary caffeine concentration were not associated with elevated serum PSA, after adjusting for confounders. Prospective studies that investigate relationships among caffeine intake and prostatic inflammation are warranted.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.